Gemifloxacin

DRUG3 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), Assiut University, Tanta University

Conditions

GonorrhoeaRhinoscleromaSpontaneous Bacterial Peritonitis

Early Phase 1

Comparison Between Rifampicin and Gemifloxacin and Ciprofloxacin in Treatment of Rhinoscleroma

Assiut UniversityRhinoscleroma

Start: 2018-02-28End: 2018-10-31Target: 60Updated: 2018-02-13

Phase 3

Oral Gemifloxacin Versus Intravenous Cefotaxime in Treatment of Spontaneous Bacterial Peritonitis

RecruitingNCT04168099

Tanta UniversitySpontaneous Bacterial Peritonitis

Start: 2018-12-01End: 2028-12-30Target: 60Updated: 2019-11-19

Phase 4

Efficacy of Combination Therapies for Gonorrhea Treatment

CompletedNCT00926796

National Institute of Allergy and Infectious Diseases (NIAID)Gonorrhoea

Start: 2010-06-30End: 2013-05-31Updated: 2015-08-19

Related Papers

The Efficacy and Safety of Gentamicin Plus Azithromycin and Gemifloxacin Plus Azithromycin as Treatment of Uncomplicated Gonorrhea

Clinical Infectious Diseases2014-07-16145 citations